Identifying Tandem Repeat Expansion-Mediated Mechanisms of Autism-Risk Genes

Strategic Insights -

Researchers have long struggled to understand the complexities of autism spectrum disorder (ASD), a set of neurodevelopmental conditions affecting communication and social interactions. Despite hundreds of genes known to confer a risk, most ASD cases remain idiopathic, with a critical barrier to progress being the identification of additional ASD-risk genes. A recent study has uncovered noncoding tandem repeat (TR) mutations that may account for 4% of idiopathic ASD cases, highlighting an uncharted territory in need of investigation. The goal of this project is to identify high-confident TR mutations in ASD, elucidate their molecular mechanisms, and demonstrate their adverse effects on host genes.

Key Takeaways:

  • The National Institute of General Medical Sciences has awarded a $0.75M grant to Lukasz J. Sznajder for a project titled "Identifying tandem repeat expansion-mediated mechanisms of autism-risk genes."
  • Autism spectrum disorder (ASD) has a high heritability rate, with hundreds of genes known to confer a risk for the condition, but most ASD cases remain idiopathic.
  • Tandem repeats (TR) account for approximately 5% of the human genome and have been suggested to account for approximately 4% of idiopathic ASD cases.
  • Recent genome studies have uncovered previously undetected and predominantly noncoding TR mutations in ASD.
  • The project aims to identify high-confident TR mutations in ASD, elucidate their molecular mechanisms, and demonstrate their adverse effects on host genes.
  • The project has the potential to profoundly impact our understanding of ASD and inform future biomarker and therapeutic strategy development.
  • The State of Nevada and the University of Nevada have recognized the importance of this research, as demonstrated by the award of the grant to Lukasz J. Sznajder.

Statistics:

  • $0.75M: The amount of an NIH R16 grant awarded to Lukasz J. Sznajder for the project.
  • 5%: The proportion of the human genome accounted for by tandem repeats (TR).
  • 4%: The proportion of idiopathic ASD cases that may be accounted for by TR mutations.
  • Hundreds: The number of genes known to confer a risk for ASD.
  • Approximately 5% of the human genome: The proportion of the genome accounted for by TR.
  • Approximately 4% of idiopathic ASD cases: The proportion of ASD cases that may be accounted for by TR mutations.

Sources:

  • [Carson, University of Nevada, State of the Nevada]
  • National Institute of General Medical Sciences
  • Biochemistry, Lukasz J. Sznajder (University of Nevada)